Searched for
BRANDED FORMULATIONS BUSINESS
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
Payoneer India Cross-Border Excellence Awards 2026: From fashion to wellness, spotlighting India's e-commerce export championsThe Payoneer India Cross-Border Excellence Awards 2026 celebrate India's rising exporters, spotlighting e-commerce leaders in fashion, home...
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
L’Oréal buys control of Innovist as India beauty battle intensifiesL'Oréal SA is acquiring a majority stake in Indian beauty startup Innovist. This move strengthens L'Oréal's position in India's rapidly exp...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Hexagon Nutrition shares list at 7% premium over IPO price on boursesHexagon Nutrition debuted at a premium of up to 7.2% over its IPO price, in line with grey market expectations. The Rs 138.9 crore issue wa...
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
A new-age thirst for beverages is emerging as a key force in India's consumer goods marketBeverage industry in India: Indian companies are seeing strong growth in drinks like coffee, ready-to-drink options, and protein beverages....
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Iran war: Fuel price surge squeezes dairy, poultry value chainsIndustry officials say rising fuel costs, coupled with geopolitical disruptions affecting commodity markets, are squeezing farmer margins a...
Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
Hexagon Nutrition IPO Day 2: GMP signals 15% listing gain; Retail portion subscribed 2.43xHexagon Nutrition’s Rs 139 crore IPO saw strong retail demand on Day 2, with the retail portion subscribed 2.43 times. The grey market prem...
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
IPO Calendar: Investors to get 2 mainboard public offers this week after a month of lullIndia’s IPO market is set to revive with two mainboard issues, CMR Green Technologies and Hexagon Nutrition, opening this week after a lull...
Fredun Pharmaceuticals board approves 2:1 bonus issueFredun Pharmaceuticals’ board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to r...